Vivani Medical raises $8.25M through private placement for drug development

From GlobeNewswire: 2025-03-27 07:32:00

Vivani Medical, Inc. has strengthened its balance sheet with a private placement of 7,366,071 shares, raising approximately $8.25 million. This financing extends the company’s cash runway into the second quarter of 2026, allowing for accelerated development of NPM-139 and NPM-115, both GLP-1 implants for chronic weight management. The private placement was priced “at-the-market” and has multiple closing dates. These securities have not been registered under the Securities Act and may only be sold under certain exemptions. Vivani is focused on developing long-acting drug implants to improve patient adherence and effectiveness of medication.



Read more at GlobeNewswire: Vivani Medical Announces $8.25M Private Placement Equity